CTNS mutations in patients with cystinosis.

Mitochondrial autophagy promotes cellular injury in nephropathic cystinosis. J Am Soc Nephrol (2009) 1.86

Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter. EMBO J (2001) 1.83

Cystinosis: practical tools for diagnosis and treatment. Pediatr Nephrol (2010) 1.24

Genetic basis of cystinosis in Turkish patients: a single-center experience. Pediatr Nephrol (2011) 1.00

Late-onset nephropathic cystinosis: clinical presentation, outcome, and genotyping. Clin J Am Soc Nephrol (2008) 0.99

Impairment of chaperone-mediated autophagy leads to selective lysosomal degradation defects in the lysosomal storage disease cystinosis. EMBO Mol Med (2015) 0.86

The promoter of a lysosomal membrane transporter gene, CTNS, binds Sp-1, shares sequences with the promoter of an adjacent gene, CARKL, and causes cystinosis if mutated in a critical region. Am J Hum Genet (2001) 0.86

Insights into novel cellular injury mechanisms by gene expression profiling in nephropathic cystinosis. J Inherit Metab Dis (2010) 0.85

Cysteamine, the molecule used to treat cystinosis, potentiates the antimalarial efficacy of artemisinin. Antimicrob Agents Chemother (2010) 0.84

Cysteamine, the natural metabolite of pantetheinase, shows specific activity against Plasmodium. Exp Parasitol (2010) 0.82

End-stage renal failure as manifestation of adolescent cystinosis. Eur J Pediatr (2004) 0.77

Evaluation of topical cysteamine therapy in the CTNS(-/-) knockout mouse using in vivo confocal microscopy. Mol Vis (2011) 0.76

A case of corneal cystinosis in a patient with rickets and chronic renal failure. Indian J Ophthalmol (2015) 0.75

Chemical individuality: concept and outlook. J Inherit Metab Dis (2008) 0.75

The Clinical and Mutational Spectrum of Turkish Patients with Cystinosis. Clin J Am Soc Nephrol (2017) 0.75

Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor. Mol Cell (1999) 4.67

Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis. Science (1982) 2.49

Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome). N Engl J Med (1998) 2.42

Occipital horn syndrome and a mild Menkes phenotype associated with splice site mutations at the MNK locus. Nat Genet (1994) 2.25

Improved renal function in children with cystinosis treated with cysteamine. N Engl J Med (1993) 1.98

Defective cystine exodus from isolated lysosome-rich fractions of cystinotic leucocytes. J Biol Chem (1982) 1.94

Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med (1987) 1.92

Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome. Mol Genet Metab (1999) 1.91

Pulmonary function and high-resolution CT findings in patients with an inherited form of pulmonary fibrosis, Hermansky-Pudlak syndrome, due to mutations in HPS-1. Chest (2000) 1.90

Mutation of a new gene causes a unique form of Hermansky-Pudlak syndrome in a genetic isolate of central Puerto Rico. Nat Genet (2001) 1.83

Early copper therapy in classic Menkes disease patients with a novel splicing mutation. Ann Neurol (1995) 1.82

The α-granule proteome: novel proteins in normal and ghost granules in gray platelet syndrome. J Thromb Haemost (2010) 1.73

Clinical biochemical and pathologic correlations in Bietti's crystalline dystrophy. Am J Ophthalmol (1994) 1.70

Molecular cloning and characterization of rab27a and rab27b, novel human rab proteins shared by melanocytes and platelets. Biochem Mol Med (1997) 1.63

Classic nephropathic cystinosis as an adult disease. JAMA (1993) 1.62

A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol Psychiatry (2010) 1.61

AP-3 mediates tyrosinase but not TRP-1 trafficking in human melanocytes. Mol Biol Cell (2001) 1.60

Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews. Am J Hum Genet (2001) 1.56

Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage. Ann Neurol (1994) 1.55

Significant association between IRF6 820G->A and non-syndromic cleft lip with or without cleft palate in the Thai population. J Med Genet (2005) 1.54

Molecular characterization of the protein encoded by the Hermansky-Pudlak syndrome type 1 gene. J Biol Chem (2000) 1.51

Mutations in 3 genes (MKS3, CC2D2A and RPGRIP1L) cause COACH syndrome (Joubert syndrome with congenital hepatic fibrosis). J Med Genet (2009) 1.50

Indian childhood cirrhosis in an American child. Gastroenterology (1992) 1.47

The metabolism of fatty acids in human Bietti crystalline dystrophy. Invest Ophthalmol Vis Sci (2001) 1.46

CTNS mutations in an American-based population of cystinosis patients. Am J Hum Genet (1998) 1.41

Defective sialic acid egress from isolated fibroblast lysosomes of patients with Salla disease. Science (1986) 1.41

Clinical and laboratory findings in the oculocerebrorenal syndrome of Lowe, with special reference to growth and renal function. N Engl J Med (1991) 1.41

Effect of growth hormone treatment on serum creatinine concentration in patients with cystinosis and chronic renal disease. J Pediatr (1992) 1.40

Characteristics of cystine counter-transport in normal and cystinotic lysosome-rich leucocyte granular fractions. Biochem J (1983) 1.40

Hermansky-Pudlak syndrome and related disorders of organelle formation. Traffic (2000) 1.40

Proteomic analysis of platelet alpha-granules using mass spectrometry. J Thromb Haemost (2007) 1.40

NTBC and alkaptonuria. Am J Hum Genet (1998) 1.38

The genomic region encompassing the nephropathic cystinosis gene (CTNS): complete sequencing of a 200-kb segment and discovery of a novel gene within the common cystinosis-causing deletion. Genome Res (2000) 1.32

Plasma and cerebrospinal fluid neurochemical pattern in Menkes disease. Ann Neurol (1993) 1.32

Hermansky-Pudlak syndrome type 3 in Ashkenazi Jews and other non-Puerto Rican patients with hypopigmentation and platelet storage-pool deficiency. Am J Hum Genet (2001) 1.28

A new variant of Hermansky-Pudlak syndrome due to mutations in a gene responsible for vesicle formation. Am J Med (2000) 1.27

Patterns of amino acid efflux from isolated normal and cystinotic human leucocyte lysosomes. J Biol Chem (1982) 1.25

Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis. J Clin Endocrinol Metab (1995) 1.24

Cystine accumulation and clearance by normal and cystinotic leukocytes exposed to cystine dimethyl ester. Proc Natl Acad Sci U S A (1982) 1.21

Identification and detection of the common 65-kb deletion breakpoint in the nephropathic cystinosis gene (CTNS). Mol Genet Metab (1999) 1.21

Successful early copper therapy in Menkes disease associated with a mutant transcript containing a small In-frame deletion. Biochem Mol Med (1996) 1.20

Hermansky-Pudlak syndrome: models for intracellular vesicle formation. Mol Genet Metab (1998) 1.20

A mutation of the p63 gene in non-syndromic cleft lip. J Med Genet (2006) 1.16

Mutations in the human UDP-N-acetylglucosamine 2-epimerase gene define the disease sialuria and the allosteric site of the enzyme. Am J Hum Genet (1999) 1.16

A comparison of the effectiveness of cysteamine and phosphocysteamine in elevating plasma cysteamine concentration and decreasing leukocyte free cystine in nephropathic cystinosis. Pediatr Res (1988) 1.14

Disorders of vesicles of lysosomal lineage: the Hermansky-Pudlak syndromes. Curr Mol Med (2002) 1.14

Mutations in the glutathione synthetase gene cause 5-oxoprolinuria. Nat Genet (1996) 1.10

Molecular cloning and characterization of human VPS18, VPS 11, VPS16, and VPS33. Gene (2001) 1.10

Defective lysosomal egress of free sialic acid (N-acetylneuraminic acid) in fibroblasts of patients with infantile free sialic acid storage disease. J Biol Chem (1989) 1.10

Transamination of methionine in humans. Clin Sci (Lond) (1989) 1.10

Long-term ocular manifestations in nephropathic cystinosis. Arch Ophthalmol (1986) 1.09

Cysteamine depletes cystinotic leucocyte granular fractions of cystine by the mechanism of disulphide interchange. Biochem J (1985) 1.08

Ocular nonnephropathic cystinosis: clinical, biochemical, and molecular correlations. Pediatr Res (2000) 1.07

Plasma amino acids in appropriate- and small-for-gestational-age fetuses. Am J Obstet Gynecol (1989) 1.07

Lysosomal cystine counter-transport in heterozygotes for cystinosis. Am J Hum Genet (1984) 1.07

Altered protein localization in melanocytes from Hermansky-Pudlak syndrome: support for the role of the HPS gene product in intracellular trafficking. Lab Invest (1998) 1.07

Distal vacuolar myopathy in nephropathic cystinosis. Ann Neurol (1994) 1.04

Blunted prolactin response to thyrotropin-releasing hormone stimulation in cystinotic children receiving cysteamine. J Clin Endocrinol Metab (1985) 1.04

Recent advances in the treatment of cystinosis. J Inherit Metab Dis (1995) 1.04

Course of nephropathic cystinosis after age 10 years. J Pediatr (1986) 1.04

Abnormal synthesis of dolichol-linked oligosaccharides in carbohydrate-deficient glycoprotein syndrome. Glycobiology (1995) 1.03

A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosis. Mol Genet Metab (1998) 1.02

Sialic acid metabolism in sialuria fibroblasts. J Biol Chem (1991) 1.02

Cystinosis coming of age. Adv Pediatr (1986) 1.02

Bilateral submandibular gland aplasia with clinico-radiological mass due to prolapsing sublingual salivary tissue through mylohyoid boutonniere: a case report and review. Dentomaxillofac Radiol (2009) 1.01

Predictive value of plasma catecholamine levels in neonatal detection of Menkes disease. J Inherit Metab Dis (1993) 1.01

Removal of corneal crystals by topical cysteamine in nephropathic cystinosis. N Engl J Med (1987) 1.00

Neurologic complications in long-standing nephropathic cystinosis. Arch Neurol (1989) 1.00

Heterozygote detection in cystinosis, using leukocytes exposed to cystine dimethyl ester. N Engl J Med (1982) 0.99

Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome. J Clin Invest (1985) 0.99

Polyamine degradation in foetal and adult bovine serum. Biochem J (1982) 0.99

Intracellular distribution of lysosomal sialidase is controlled by the internalization signal in its cytoplasmic tail. J Biol Chem (2001) 0.99

Clinical and cellular characterisation of Hermansky-Pudlak syndrome type 6. J Med Genet (2009) 0.98

Hermansky-Pudlak syndrome and Chediak-Higashi syndrome: disorders of vesicle formation and trafficking. Thromb Haemost (2001) 0.98

Association of CD247 with systemic lupus erythematosus in Asian populations. Lupus (2011) 0.98

Two missense mutations causing tyrosinemia type 1 with presence and absence of immunoreactive fumarylacetoacetase. Hum Genet (1994) 0.97

A randomized placebo-controlled trial of cysteamine eye drops in nephropathic cystinosis. Arch Ophthalmol (1990) 0.96

TBX22 mutations are a frequent cause of non-syndromic cleft palate in the Thai population. Clin Genet (2007) 0.96

Characteristics of a lysosomal membrane transport system for tyrosine and other neutral amino acids in rat thyroid cells. J Biol Chem (1986) 0.96

Evidence for locus heterogeneity in Puerto Ricans with Hermansky-Pudlak syndrome. Am J Hum Genet (1997) 0.95

Carbohydrate-deficient glycoprotein syndrome. Adv Pediatr (1997) 0.95

Identification of the metabolic defect in sialuria. J Biol Chem (1989) 0.95

A new genetic isolate of gray platelet syndrome (GPS): clinical, cellular, and hematologic characteristics. Mol Genet Metab (2001) 0.94

Three novel mutations in the PORCN gene underlying focal dermal hypoplasia. Clin Genet (2008) 0.94

Pulmonary dysfunction in adults with nephropathic cystinosis. Chest (2001) 0.94

Fine mapping of the cystinosis gene using an integrated genetic and physical map of a region within human chromosome band 17p13. Biochem Mol Med (1996) 0.94

Molecular cloning of two novel rab genes from human melanocytes. Gene (1996) 0.94

pH effects on cystine transport in lysosome-rich leucocyte granular fractions. Biochem J (1985) 0.94

Clinical and molecular aspects of nephropathic cystinosis. J Mol Med (Berl) (1998) 0.94

Trafficking of major histocompatibility complex class II molecules in human B-lymphoblasts deficient in the AP-3 adaptor complex. Immunol Lett (2000) 0.93

Hepatic methionine adenosyltransferase deficiency in a 31-year-old man. Am J Hum Genet (1987) 0.93

P gene mutations in patients with oculocutaneous albinism and findings suggestive of Hermansky-Pudlak syndrome. J Med Genet (2004) 0.93

Pancreatic endocrine insufficiency in posttransplant cystinosis. Am J Dis Child (1987) 0.93

Nephropathic cystinosis: immunohistochemical and histopathologic studies of cornea, conjunctiva and iris. Curr Eye Res (1987) 0.92